STATEMENT   

 
   

STATEMENT OF SENATOR CARL LEVIN (D-MI)
BEFORE THE
PERMANENT SUBCOMMITTEE ON INVESTIGATIONS
ON
SARS: BEST PRACTICES FOR IDENTIFYING AND CARING FOR NEW CASES

July 30, 2003

I want to begin by commending Sen. Coleman for holding this hearing to push for the development of best practices for responding to SARS cases before there is an immediate problem. Advance planning now can save lives and prevent future confusion, concern, and unnecessary costs.

SARS is a disease that we cannot afford to ignore. Its global impact has already been significant. Cases have been reported in approximately 30 countries. Over 800 individuals have died, while hundreds more have suffered and recovered. Hospitals, quarantine facilities, and health resources have been strained. Global travel has been disrupted and just recently restored. Economists are struggling to evaluate SARS’ economic impact on China and Canada. Experts are warning of a possible SARS epidemic in developing regions of the world, where health care systems are not equipped to deal with rapid, large-scale infection.

Here in the United States, we have so far avoided having to deal with high levels of infection. But as I said in the last hearing on this issue, while we can try to isolate SARS patients, we can’t isolate our nation from this disease. SARS has already made its way across our borders in several instances, and it is crucial that we establish best practices for identifying, treating, and halting this illness. While we can hope for the best, we must prepare for the worst.

Despite positive steps to deal with the virus, important problems and questions remain unanswered. Health officials responding to reported SARS cases need better guidance on how best to protect their communities and the country, without implementing measures that may be costly and excessive. For example, they must determine an appropriate degree of screening for hospital patients and staff, determine how best to handle patients suspected of carrying the disease, and establish plans in the event of a SARS outbreak involving multiple patients. They need to know how to communicate what is happening in their local communities to the nation’s SARS specialists. In addition, health officials must decide how best to inform the public about the disease without causing undue concern or panic.

We also need to deepen our understanding of the disease itself. We need to develop a rapid, accurate testing procedure for SARS, determine how the disease is transmitted, and identify high risk populations. Individuals need to know whether they have or are likely to contract the disease. Doctors need to be able to quickly diagnose and treat their patients. And health officials need to know whether their communities are at risk for high rates of infection.

I look forward to the testimony of the General Accounting Office and the Centers for Disease Control. The American public will be better prepared to stop future SARS cases, because of the work of the witnesses here before us today.

###

 

 

 


Committee Members
| Subcommittees | Hearings | Key Legislation | Jurisdiction
 
Press Statements | Current Issues | Video of Select Hearings | Sites of Interest